Lab Stein

active

Founded in Costa Rica, Corporación Stein (“Stein” or the “Company”) is a private, family-owned pharmaceutical group focused on the development, manufacture and commercialization of high-specialty generics. It has operating subsidiaries in six countries and sales in more than 20 countries across LAC, including all countries in Central America. Stein has a manufacturing facility in Costa Rica focused on the production of generics. The Company is also engaged in the commercialization of a diversified high-specialty portfolio that includes biosimilars, innovative products, and orphan drugs licensed from global pharmaceutical companies. The Company is focused on the institutional market with over 90% of revenues coming from the public sector.The proposed IFC’s financing aims to support Stein’s growth plan in LAC which includes expansion in the biosimilar, innovative, and orphan drugs segments through new licensing agreements and inorganic growth.